Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-06

Clinical Trial Update: Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya [Phase 4]

View source ↗

Summary

A Phase 4 trial in Kenya compared intermittent preventive treatment with dihydroartemisinin-piperaquine to intermittent preventive treatment with sulfadoxine-py…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Kenya Medical Research Institute | Conditions: Pregnancy, Malaria | Phase 4 | Status: COMPLETED